🇮🇪Ireland
16°C Partly Cloudy · Dublin
Live Updates
--:--:-- IST
Contributor sign in
Latest
Clinical Trials in Spain / NCT05682235
Active, not recruiting Not applicable

Therapeutic Exercise and Education in Pain Neurophysiology to Improve Pain Intensity in Women With Endometriosis. Clinical Trial.

NCT05682235 · tracked via the Priya Life Science Spain tracker
Sponsor
University of Valladolid
Phase
Not applicable
Started
2022-12-12
Last updated
2025-03-17

Condition(s) studied

Endometriosis

Investigational drug(s) / intervention(s)

Therapeutic exercise AND pain neurophysiology educationSham

Therapeutic exercise AND pain neurophysiology education: A program of therapeutic exercise and education in the neurophysiology of pain will be applied to the participants of the experimental group and talks on healthy habits to the placebo group participants.

Sham: Talk about healthy habits

Study summary

The objective of this study will be to evaluate treatment using ET exercise and pain education in women with endometriosis to improve pain intensity.

Eligibility

Sex
FEMALE
Min age
18 Years
Max age
45 Years
Healthy volunteers
No
Inclusion Criteria: * Women of reproductive age between 18 and 45 years. * Women with a medical diagnosis of endometriosis. * Women with visual analog scale (EVA) between 4 and 10 (moderate-severe pain) during the last 3 months in the suprapubic area, abdomen or perineum both continuously and intermittently. Exclusion Criteria: * Women who must have surgery during the study. * Women who have undergone abdominal or pelvic surgery or who have given birth (vaginal or cesarean) in the last 6 months. * Women who are pregnant or planning a pregnancy. * Women with uncorrected pacemakers or coagulopathies, severe comorbid disorder, cancer (in the last 5 years or at present), severe mental disorders, or neuropathies affecting the nerves of the pelvis or lower extremities. * Physiotherapy treatments or treatments related to pathology or study areas 15 days prior to the beginning of the study. * Variations in medication in the 3 months prior to the start of the study.

Primary outcome measure(s)

Trial sites (1)

FacilityCityRegionStatus
University of Valladolid Valladolid Spain

More University of Valladolid trials in Spain

Other trials for the same condition

Official registry record

This page summarises publicly available registry data for informational purposes — not medical advice. Eligibility is determined by each study team; patients should discuss participation with their clinician.

View NCT05682235 on ClinicalTrials.gov ↗ ← All trials in Spain